Orasure Technologies (OSUR) Current Deferred Revenue (2011 - 2025)
Orasure Technologies (OSUR) posted Current Deferred Revenue of $1.5 million for Q4 2025, down 20.11% sequentially from $1.9 million in Q3 2025, and down 49.4% YoY from $3.0 million in Q4 2024.
Orasure Technologies (OSUR) Current Deferred Revenue (2011 - 2025) Analysis & Trends
Orasure Technologies has reported Current Deferred Revenue for 15 years, with the latest figure at $1.5 million in Q4 2025.
- Quarterly Current Deferred Revenue fell 49.4% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 49.4% YoY) and the FY2025 annual result came in at $1.5 million, down 49.4% from the prior year.
- Current Deferred Revenue declined to $1.5 million in Q4 2025 per OSUR's latest filing, from $1.9 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $4.6 million in Q1 2021 and troughed at $771000.0 in Q1 2025.
- A 5-year average of $2.3 million and a median of $2.1 million in 2022 frame the typical range for Current Deferred Revenue.
- The widest YoY moves for Current Deferred Revenue: up 151.26% in 2024, down 61.09% in 2024.
- Over 5 years, Current Deferred Revenue stood at $2.9 million in 2021, then fell by 22.58% to $2.3 million in 2022, then tumbled by 47.47% to $1.2 million in 2023, then surged by 151.26% to $3.0 million in 2024, then slumped by 49.4% to $1.5 million in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.5 million, $1.9 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Orasure Technologies | 282.89 Mn | 83.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 771,000.00 |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 774,000.00 |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.54 Mn |
| Jun 30, 2022 | 2.66 Mn |
| Mar 31, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2.94 Mn |
| Sep 30, 2021 | 3.49 Mn |
| Jun 30, 2021 | 4.24 Mn |
| Mar 31, 2021 | 4.58 Mn |